These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25874339)

  • 1. Synthesis of a novel class of substituted benzothiophene or benzofuran derivatives as BMP-2 up-regulators and evaluation of the BMP-2-up-regulating effects in vitro and the effects on glucocorticoid-induced osteoporosis in rats.
    Xue ST; Guo HF; Liu MJ; Jin J; Ju DH; Liu ZY; Li ZR
    Eur J Med Chem; 2015; 96():151-61. PubMed ID: 25874339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted benzothiophene or benzofuran derivatives as a novel class of bone morphogenetic protein-2 up-regulators: synthesis, structure-activity relationships, and preventive bone loss efficacies in senescence accelerated mice (SAMP6) and ovariectomized rats.
    Guo HF; Shao HY; Yang ZY; Xue ST; Li X; Liu ZY; He XB; Jiang JD; Zhang YQ; Si SY; Li ZR
    J Med Chem; 2010 Feb; 53(4):1819-29. PubMed ID: 20088515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted benzothiophene and benzofuran derivatives as a novel class of bone morphogenetic Protein-2 upregulators: Synthesis, anti-osteoporosis efficacies in ovariectomized rats and a zebrafish model, and ADME properties.
    Xue ST; Zhang L; Xie ZS; Jin J; Guo HF; Yi H; Liu ZY; Li ZR
    Eur J Med Chem; 2020 Aug; 200():112465. PubMed ID: 32480301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 1-(benzo[b]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor.
    Liu ZY; He XB; Yang ZY; Shao HY; Li X; Guo HF; Zhang YQ; Si SY; Li ZR
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4167-70. PubMed ID: 19524435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and study of benzofuran-pyran analogs as BMP-2 targeted osteogenic agents.
    Kushwaha P; Tripathi AK; Gupta S; Kothari P; Upadhyay A; Ahmad N; Sharma T; Siddiqi MI; Trivedi R; Sashidhara KV
    Eur J Med Chem; 2018 Aug; 156():103-117. PubMed ID: 30006156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 2: 7-fluorobenzothiophenes and benzofurans.
    Marastoni E; Bartoli S; Berettoni M; Cipollone A; Ettorre A; Fincham CI; Mauro S; Paris M; Porcelloni M; Bigioni M; Binaschi M; Nardelli F; Parlani M; Maggi CA; Paoli P; Rossi P; Fattori D
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1603-6. PubMed ID: 25746815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis.
    Zhou ZY; Sun LQ; Han XY; Wang YJ; Xie ZS; Xue ST; Li ZR
    J Med Chem; 2023 Feb; 66(3):1742-1760. PubMed ID: 36662031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzofuran-dihydropyridine hybrids: A new class of potential bone anabolic agents.
    Modukuri RK; Choudhary D; Gupta S; Rao KB; Adhikary S; Sharma T; Siddiqi MI; Trivedi R; Sashidhara KV
    Bioorg Med Chem; 2017 Dec; 25(24):6450-6466. PubMed ID: 29097030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor delta agonists.
    Filzen GF; Bratton L; Cheng XM; Erasga N; Geyer A; Lee C; Lu G; Pulaski J; Sorenson RJ; Unangst PC; Trivedi BK; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3630-5. PubMed ID: 17512197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney tissue targeted metabolic profiling of glucocorticoid-induced osteoporosis and the proposed therapeutic effects of Rhizoma Drynariae studied using UHPLC/MS/MS.
    Huang Y; Liu X; Zhao L; Li F; Xiong Z
    Biomed Chromatogr; 2014 Jun; 28(6):878-84. PubMed ID: 24861758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations.
    Belal A; Elkady H; Al-Karmalawy AA; Amin AH; Ghoneim MM; El-Sherbiny M; Al-Serwi RH; Abdou MA; Ibrahim MH; Mehany ABM
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of implantation of biodegradable magnesium alloy on BMP-2 expression in bone of ovariectomized osteoporosis rats.
    Guo Y; Ren L; Liu C; Yuan Y; Lin X; Tan L; Chen S; Yang K; Mei X
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4470-4. PubMed ID: 23910367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, discovery and preliminary SAR study of benzofuran derivatives as angiogenesis inhibitors.
    Chen Y; Chen S; Lu X; Cheng H; Ou Y; Cheng H; Zhou GC
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1851-4. PubMed ID: 19272775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of benzothiophene carboxamide derivatives and their pharmacological evaluation as potent antihypertriglyceridemic agents in rats.
    Abu Sheikha G; Hussin B; Al-Hiari Y; Al-Qirim T; Shattat G
    Z Naturforsch C J Biosci; 2011; 66(3-4):93-103. PubMed ID: 21630582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities.
    Perspicace E; Cozzoli L; Gargano EM; Hanke N; Carotti A; Hartmann RW; Marchais-Oberwinkler S
    Eur J Med Chem; 2014 Aug; 83():317-37. PubMed ID: 24974351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced osteogenic activity of bone morphogenetic protein-2 by 2-O-desulfated heparin.
    Ratanavaraporn J; Tabata Y
    Acta Biomater; 2012 Jan; 8(1):173-82. PubMed ID: 22005328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.